The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The stakes for media and tech companies have never been higher, even if attention spans have never been shorter.
Cars with Drive Pilot are only available for sale in California and Nevada, and even there it only works on certain freeways.
The potential sale is playing out against a larger deal as Australian rival BHP has offered to buy parent Anglo American for $39 billion.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Despite Humane’s lofty dreams to disrupt the smartphone status quo, critics have not been thrilled with the startup’s debut device.
GM said it grew market share across several pickup and SUV models, despite pricing incentives that were “well below” the industry average.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
How tech firms reconcile their desire for endless growth with bold climate goals.
A new survey finds evidence that “the drugs have a meaningful impact on consumer behavior and spending on groceries and restaurants.”
Shares are at a 15-month low amid a pile-up of bad news, as analysts call for a course correction, and production woes continue to mount.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.